Following the successful MSC-based treatment of a life-threatening respiratory syndrome associated with the filamin A (FLNA) gene mutation in a child [12], we performed this therapeutic approach as a rescue therapy in a child with chronic respiratory failure associated with SP-C dysfunction. The gene discussed is SFTPC; the disease is respiratory failure.